°Ç¸ç³Ô¹Ï

Skip to main content
FOI release

VMD FOI/EIR Requests February 2026

Freedom of Information/Environmental Information Regulation requests for February 2026.

From:
Veterinary Medicines Directorate
Published
22 May 2026

Documents

FOI2026/00235 – Marketing Authorisation Holders & List of products containing Fipronil and Imidacloprid products

HTML

FOI2026/00237 – Case reports on Apoquel

HTML

FOI2026/00254 – Communications between the VMD and other bodies

HTML

FOI2026/00266 – VMD financial interest with Zoetis

HTML

PDF, 415 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email postmaster@vmd.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

FOI2026/00267 – Annual benefit-risk reports (BRRs) from MAHs

HTML

FOI2026/00270 – Applications for Lenivia (izenivetmab) and Portela (relfovetmab)

HTML

FOI2026/00291 – Adverse events reported of rapidly progressive arthritis following Solensia

HTML

FOI2026/00305 – VPC Software Based Data Destruction Assurance

HTML

FOI2026/00306 – VMD Software Based Data Destruction Assurance

HTML

FOI2026/00315 – Legal category changes for VMPs

HTML

FOI2026/00324 – Librela (bedinvetmab) adverse event reports

HTML

FOI2026/00338 – Specific adverse event report

HTML

PDF, 135 KB, 6 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email postmaster@vmd.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 778 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email postmaster@vmd.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

FOI2026/00340 – Cancer medicine usage across the UK

HTML

FOI2026/00341 – Diversion of Veterinary Sedatives into Illicit Drug Supply

HTML

FOI2026/00342 – Annual completed benefit-risk reports (BRRs)

HTML

FOI2026/00349 – Availability of Masivet 150 mg (masitinib)

HTML

FOI2026/00351 – Librela adverse events and data sheets

HTML

FOI2026/00379 – Funding Received from Zoetis (Last 5 Years)

HTML

FOI2026/00380 – Adverse events numbers for specific products

HTML

FOI2026/00475 – List of generic email addresses for MAH

HTML

Details

The responses to FOI/EIR requests received in February 2026 are published here.

Updates to this page

Published 22 May 2026

Sign up for emails or print this page